XML 75 R61.htm IDEA: XBRL DOCUMENT v3.20.4
Fair value of financial instruments and investments - Summary of changes in the fair value of the Company's Level 3 valuation (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
SARs    
Changes in the fair value of warrant liability and SARs liability    
Ending Balance $ 0  
Level 3    
Changes in the fair value of warrant liability and SARs liability    
Ending Balance 101,200  
Level 3 | SARs    
Changes in the fair value of warrant liability and SARs liability    
Beginning Balance 3,186 $ 3,814
Additions 0 0
Change in fair value 0 3,187
Payments (3,186) (3,815)
Rights Exchange settlement 0  
Ending Balance 0 3,186
Development and Regulatory Milestone | Level 3 | Agilis | Contingent Consideration Payable    
Changes in the fair value of warrant liability and SARs liability    
Beginning Balance 290,500 257,040
Additions 0 0
Change in fair value (12,120) 33,460
Payments 0 0
Rights Exchange settlement (139,180)  
Ending Balance 139,200 290,500
Net Sales Milestones and Royalties | Level 3 | Agilis | Contingent Consideration Payable    
Changes in the fair value of warrant liability and SARs liability    
Beginning Balance 65,800 53,200
Additions 0 0
Change in fair value 35,400 12,600
Payments 0 0
Rights Exchange settlement 0  
Ending Balance $ 101,200 $ 65,800